|

A study conducted by The National Initiative For Children’s Healthcare Quality, using a new scientific detection method, has determined that for every 100 hospitalized children, there are 11 drug-related harmful events. These include medicine mix-ups, accidental overdoses, and bad drug reactions. This new estimate translates to more than 7% of hospitalized children, or approximately 540,000 children annually, based on government data. The new method uses a list of 15 “triggers” on children’s charts, including use of specific antidotes for drug overdoses, suspicious side effects and various lab tests.

The results will be made available to the public in the April issue of the journal Pediatrics. Experts say that the problem is larger than the study concludes, because it only reviewed selected charts, and didn’t include results from general community hospitals, where most U.S. children are treated.

|

Supplementing our February 29, 2008 post “Blood Thinner Heparin Tied To Several Deaths“, the actor Dennis Quaid appeared on “60 Minutes” last Sunday to reveal every parent’s nightmare: He and his wife almost lost their newborn twins last year at Cedar’s Sinai Hospital in Los Angeles due to a massive overdose of the blood thinner Heparin, manufactured by Baxter International.

The nurses were supposed to give the twins a dosage of “Hep-Lock”, a weak form of Heparin to keep IV lines open. Instead, they gave the twins Heparin in a dosage which Quaid described as “10,000 times the normal dosage”, causing a drug overdose which could have been fatal. Apparently the almost tragic mistake was caused by the very similar blue backgrounds on the vials of Hep-Lock and Heparin. Quaid said that “our kids were bleeding from everyplace they were punctured…it was blood everywhere.”

Shockingly, this same event occurred in Indianapolis a year earlier, which resulted in the deaths of three infants. Despite this fact, Baxter International, being sued by the Quaids in a multi-million dollar defective product lawsuit, did not change the colors of the two vials until after the Quaid twins incident–now, one vial is red and the other is blue, making a mistake by nurses much less likely.

Continue reading ›

|

The Journal Archives of Surgery published a study on March 17th which found that a year after an injury in a car accident, slip and fall or other types of accidents, 63 percent reported that they still had substantial pain related to the injury. The over 3,000 patients studied were 18 to 84 years of age, who had survived a traumatic injury.

The people in the study suffered head injuries, broken limbs, chest or abdominal trauma and other injuries in motor vehicle crashes, slip/trip and fall accidents and other circumstances. The most common areas of pain were in the joints and limbs (44 %), the back (26 %), the head (12 %), and the neck (7 %).

The American Pain Foundation, a Baltimore-based advocacy group, said the financial cost of chronic pain in the United States, including lost income, health care expenses and lost productivity in the workplace, is estimated to be $100 billion per year. According to this foundation, back pain is the leading cause of disability in Americans under 45 years old.

Continue reading ›

|

On March 15, 2008, in a fatal New York construction accident, a construction crane collapsed on East 51rst Street in Manhattan, killied seven people and injuring several others. Aides to the Manhattan borough president, Scott Stringer, said they had been told by the Office of Emergency Management that the crane fell on two buildings, destroying one at 305 East 50th Street and partly collapsing the building at 301 East 50th Street. The big white crane which fell appeared to be about 20 stories tall, according to onlookers. Firefighters carried stretchers at the scene of the accident, as people were feared to be trapped beneath the wreckage. Apparently, just before the crane collapsed, it was lifting material that apparently fell and struck a girder that connected the crane to the building.

Construction has increasingly become a deadly business — especially in New York, where laborers routinely dangle from skyscrapers, all part of a building boom that has defied the national slowdown. In January, in another New York fatal construction accident, high-rise concrete forms collapsed at the site of Donald Trump’s hotel and condo complex in Lower Manhattan. An Ukrainian immigrant worker who was the father of several children was decapitated as he plunged 42 stories to his death. Three others were injured.

Two months earlier, another immigrant worker was killed when he fell 15 stories, prompting the creation of a task force to cut down on scaffolding accidents.

Continue reading ›

|

The United States Citizenship and Immigration Services USCIS acknowledged that due to a huge increase in applications for green cards and citizenship in July of 2007, the average waiting time for legal residency and citizenship is now 18 months. The surge in applications in July of 2007 (7 times more than the average month), which resulted in the increased waiting time from approximately 7 months to 18 months, was due to applicants submitting their papers just before the almost 50% increase in fees on July 30, 2007.

The USCIS has been under fire for not anticipating and planning for the huge increase in applications last July, although they did hire 750 additional agents for the sole purpose of working on applications. Michael Aytes, the associate director of domestic operations of USCIS has pledged that the agency will keep its promise made at the time of the increase: that in return for the higher fees, by 2010, applications for U.S. citizenship will be processed within 5 months, and petitions for green cards will be handled within four months.

This writer is somewhat skeptical about these optimistic predictions from the USCIS, but we will give the agency the benefit of the doubt and hope that these 750 extra officers will make the difference once the July 2007 surge in applications is two years behind us.

|

Following up on our blog “U.S. Supreme Court Deals Blow to Lawsuits Against Defective Products“, the Court heard arguments on February 25 in Warner-Lambert v. Kent, to determine whether drug manufacturers should receive similar protection from lawsuits that the Court handed out to medical device makers earlier in February. Judge Breyer, normally one of the Court’s most liberal justices, gave a strong indication that the Court is heading in the direction of protecting drug makers when he stated: “Who should make the decisions that will determine whether a drug is on balance, going to save people or, on balance, going to hurt people?… An expert agency, [The Food and Drug Administration] on the one hand or 12 people pulled randomly for a jury role who see before them only the people whom the drug hurt and don’t see those who need the drug to cure them.”

Seemingly forgetting about the thousands of injured victims of Vioxx, for example, who used a dangerous drug which had been approved by the F.D.A. and nevertheless suffered numerous deaths, heart attacks, and other complications, and without question needed the courts to redress their grievances, it appears that the Supreme Court is now ready to bar lawsuits against drug makers.

Continue reading ›

|

Last week, the U.S. Supreme Court ruled that private lawsuits against medical device manufacturers are not permitted when the device in question complies with federal requirements. Essentially, the Court’s decision in Riegel v. Medtronic is another example of the U.S. Supreme Court’s attack on consumer rights, and will have far reaching negative effects for those who are seriously injured by dangerous and defective products . Charles Riegel received a balloon catheter manufactured by Medtronic which ruptured due to over inflation. He developed a heart block and was forced to undergo emergency surgery to save his life.

The Riegels brought a claim in federal court in New York, which was dismissed by the court, and upheld by the U.S. Circuit Court as being preempted by the Medical Devices Amendments (MDA). The MDA precludes lawsuits against manufacturers where the device in question complied with federal requirements. The problem with the Court’s decision, as noted by Justice Ginsberg in her dissenting opinion, is what if evidence of the product’s defect becomes known after the product has received premarket approval?

The Court stated in no uncertain terms its belief that juries are not capable of evaluating the risks associated with dangerous devices, with such language by Judge Scalia as the following: “The Dalkon Shield failure and its aftermath demonstrated the inability of the common law tort system to manage the risks associated with dangerous devices.” And this quote from the opinion is even more frightening for those who believe in our civil justice system as a means to hold manufacturers of defective products accountable: “A jury on the other hand, sees only the cost of a more dangerous design, and is not concerned with its benefits; the patients who reaped those benefits are not represented in court.”

Continue reading ›

|

The Food and Drug Administration announced on February 28 that “potential deficiencies” at a Chinese plant that produces the active ingredient in Heparin, a blood thinner used to treat blood clots during dialysis and after some surgery, is a possible cause of 21 deaths, as well as hundreds of allergic reactions including vomiting, nausea and difficulty breathing. Baxter International, the company which makes the brand of Heparin that is now considered a potentially dangerous product, has announced an immediate recall of virtually all of its Heparin products, which it buys from a Chinese plant known as Changzhou SPL.

Heparin is made from pig intestines. In China and other developing countries, tracing the source of the animals used to make the product can be very difficult. The FDA also acknowledged that other problems which could have led to the manufacture of the dangerous product include the lack of specific procedures outlining removal of impurities, and no records showing the suppliers’ source of the products.

The Food and Drug Administration estimates that over one million multi-dose vials of Heparin are sold per month in the United States, and half of those are manufactured and distributed by Baxter. However, the FDA has provided assurances that there is an adequate supply in the market to meet the demand for Heparin, which clearly is a necessary and lifesaving drug.

|

Our White Plains, New York office gets numerous calls and e-mails from clients confronted with a scenario in which they have been sued for more than their insurance coverage, and they receive a notice from the insurance company stating the following: “You may wish to retain a private attorney at your own cost and expense to protect your interests over and above your insurance coverage…” For example, we have represented an orthopedist who was sued for medical malpractice in Brooklyn, New York with a claim of serious injuries as a result of improper back surgery; a client in a Westchester County motor vehicle accident who had a minimal insurance policy ($25,000) and was being sued for more than $1,000,000; and the owner of a beer and beverage mart who was sued in a Dutchess County wrongful death case by the parents of some underage teens in which the teens bought beer at the mart and served the beer at a “keg party”, resulting in the intoxication of a underaged partygoer who lost control of his car and was then involved in a horrific accident causing his death and serious injuries to four other teens.

The answer as to whether you need a private attorney involves a few significant factors. To begin with, in the case involving the Westchester County driver, one of the big issues was whether the injuries were serious enough to result in a verdict which could exceed the car insurance policy limits. In that Westchester County car crash case, the answer to the question was yes, as the policy limits were the smallest available in New York, and the injuries included a broken leg, which without question could result in a verdict of more than $25,000.

Continue reading ›

|

Almost since the inception of New York’s No-Fault Law in 1974, New York automobile insurance companies, and particularly, Allstate, State Farm, and New York Mutual Insurance, to name a few, have for years, added insult to the injury of our clients’ car accident injuries by seeking to cut off benefits as soon as possible. This, despite the fact that their insureds have loyally paid their premiums for years, and then when they need to be “In Good Hands”, instead they get a letter informing them that they are not covered for their medical treatment as a result of the accident.

The way the system works is this. When you are in a New York automobile accident, you begin to treat with an orthopedist, neurologist, chiropractor or physical therapist for your injuries. Assuming you do not have a fracture, which automatically makes you eligible for no-fault benefits as meeting the “No-Fault Threshold“, the insurance companies, sometimes as soon as two weeks after the accident, will send you to their orthopedists, neurologists, or chiropractors, who routinely and without exception will find that there is no “serious injury“, (serious injury being the legal standard you must meet to be eligible for no-fault benefits) and that no further treatment is required. The reason the insurance companies schedule these so called “IME’s” (meaning Independent Medical Examinations” despite the fact that there is absolutely nothing “independent” about them), is that they know that another way to substantiate a serious injury is through 90 days of continuous treatment within the first 180 days after an accident.

Continue reading ›